SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancer
Canadian Cancer Trials Group
Canadian Cancer Trials Group
Cytokinetics
GlaxoSmithKline
GlaxoSmithKline
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
GlaxoSmithKline
GlaxoSmithKline
GlaxoSmithKline
GlaxoSmithKline